Literature DB >> 14724288

Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation.

Shu-Chun Teng1, Yung-Yi Chen, Yi-Ning Su, Po-Chien Chou, Yu-Chi Chiang, Shun-Fu Tseng, Kou-Juey Wu.   

Abstract

The c-myc proto-oncogene encodes a ubiquitous transcription factor involved in the control of cell growth and differentiation and implicated in inducing tumorigenesis. Understanding the function of c-Myc and its role in cancer depends upon the identification of c-Myc target genes. Heat shock protein 90 (HSP90) is involved in the folding of proteins such as signal transduction molecules (Src, Raf1, cdk4) and steroid receptors and in enhancing the activity of telomerase and nitric-oxide synthase. Here we show that c-Myc directly activates HSP90A transcription. c-Myc-mediated induction of HSP90A transcription occurs in different tissues, is independent of cell proliferation, and is mediated by a c-Myc binding site in the proximal promoter region of HSP90A gene. Overexpression of HSP90A in Rat1a cells induces transformation. Short interference RNA of HSP90A/Hsp86alpha reduces transformation activity in HeLa and RatMyc cells. These results indicate that by induction of HSP90A c-Myc may control the activity of multiple signal pathways involved in cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724288     DOI: 10.1074/jbc.M308842200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells.

Authors:  Kai Yang; Hexin Shi; Rong Qi; Shaogang Sun; Yujie Tang; Bianhong Zhang; Chen Wang
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

2.  Deregulation of common genes by c-Myc and its direct target, MT-MC1.

Authors:  Kenneth R Rogulski; Debra E Cohen; David L Corcoran; Panayiotis V Benos; Edward V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics.

Authors:  Michael R Defee; Zhiqiang Qin; Lu Dai; Jennifer S Isaacs; Chris H Parsons
Journal:  Am J Cancer Res       Date:  2011-06-05       Impact factor: 6.166

4.  Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells.

Authors:  Bo-Yuan Hsiao; Chun-Chin Chen; Pei-Chen Hsieh; Tsun-Kai Chang; Yi-Chen Yeh; Yu-Chung Wu; Han-Shui Hsu; Fung-Fang Wang; Teh-Ying Chou
Journal:  J Mol Med (Berl)       Date:  2011-01-11       Impact factor: 4.599

5.  mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.

Authors:  Valerie L Sodi; Sakina Khaku; Raisa Krutilina; Luciana P Schwab; David J Vocadlo; Tiffany N Seagroves; Mauricio J Reginato
Journal:  Mol Cancer Res       Date:  2015-01-30       Impact factor: 5.852

6.  Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.

Authors:  Xiao-Yong Zhang; Lauren M DeSalle; Jagruti H Patel; Anthony J Capobianco; Duonan Yu; Andrei Thomas-Tikhonenko; Steven B McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

Review 7.  HSP90 manages the ends.

Authors:  Diane C DeZwaan; Brian C Freeman
Journal:  Trends Biochem Sci       Date:  2010-03-16       Impact factor: 13.807

8.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

9.  Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2.

Authors:  Weihua Li; Xiaohui Miao; Zhongtian Qi; Wenting Zeng; Jianxin Liang; Zengwei Liang
Journal:  Virol J       Date:  2010-02-20       Impact factor: 4.099

10.  Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.

Authors:  Letetia Jones; Guangwei Wei; Sabina Sevcikova; Vernon Phan; Sachi Jain; Angell Shieh; Jasmine C Y Wong; Min Li; Joshua Dubansky; Mei Lin Maunakea; Rachel Ochoa; George Zhu; Thelma R Tennant; Kevin M Shannon; Scott W Lowe; Michelle M Le Beau; Scott C Kogan
Journal:  J Exp Med       Date:  2010-11-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.